Direct patent infringement CAR-T cells, Part 3

The director of your institute is delighted to hear that the University of Pennsylvania voluntarily revoked their patent EP’091. He has now requested your advice regarding how to proceed with respect to producing CAR-T cells for your medical center’s patients.